Literature DB >> 10837616

Production and selection of antigen-specific fully human monoclonal antibodies from mice engineered with human Ig loci.

.   

Abstract

The ability to produce highly specific fully human monoclonal antibodies to human antigens has potential significant applications to human therapy. This review describes the creation of novel mouse strains engineered to produce a diverse repertoire of fully human antibodies in the absence of mouse antibodies. These mouse strains have been generated by introducing megabase-sized human immunoglobulin loci, containing the majority of the human antibody gene repertoire, in nearly germline configuration, into mice deficient in mouse antibody production. The mice produce high levels of human IgMkappa and IgGkappa antibodies with a diverse adult-like repertoire. Upon immunization with multiple human antigens the mice generate high affinity, antigen-specific fully human monoclonal antibodies with neutralization activity. Comparison of these mice to other strains containing limited human antibody gene repertoire underscores the importance of the large number of variable genes for faithful reproduction of functional and diverse human antibody response in mice.

Entities:  

Year:  1998        PMID: 10837616     DOI: 10.1016/s0169-409x(97)00092-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  6 in total

Review 1.  Mammary gland immunity and mastitis susceptibility.

Authors:  Lorraine M Sordillo; Katie L Streicher
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 2.  FLT3 antibody-based therapeutics for leukemia therapy.

Authors:  Yiwen Li; Zhenping Zhu
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

3.  Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice.

Authors:  Andrew J Murphy; Lynn E Macdonald; Sean Stevens; Margaret Karow; Anthony T Dore; Kevin Pobursky; Tammy T Huang; William T Poueymirou; Lakeisha Esau; Melissa Meola; Warren Mikulka; Pamela Krueger; Jeanette Fairhurst; David M Valenzuela; Nicholas Papadopoulos; George D Yancopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-25       Impact factor: 11.205

4.  Monoclonal antibody humanness score and its applications.

Authors:  Sean H Gao; Kexin Huang; Hua Tu; Adam S Adler
Journal:  BMC Biotechnol       Date:  2013-07-05       Impact factor: 2.563

Review 5.  Engineering immunity in the mammary gland.

Authors:  Andreas F Kolb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 6.  Costimulation-based immunotherapy for head and neck cancer.

Authors:  Scott E Strome; Lieping Chen
Journal:  Curr Treat Options Oncol       Date:  2004-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.